These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 220843)

  • 21. GABAergic, dopaminergic and cholinergic interaction in tremorine-induced tremors in mice.
    Shukla VK; Garg SK; Kulkarni SK
    Methods Find Exp Clin Pharmacol; 1988 Jan; 10(1):27-31. PubMed ID: 2895827
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Supersensitivity to dopamine agonists following unilateral, 6-hydroxydopamine-induced striatal lesions in mice.
    Thornburg JE; Moore KE
    J Pharmacol Exp Ther; 1975 Jan; 192(1):42-9. PubMed ID: 1168250
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Apomorphine and piribedil in rats: biochemical and pharmacologic studies.
    Butterworth RF; Poignant JC; Barbeau A
    Adv Neurol; 1975; 9():307-26. PubMed ID: 1170716
    [TBL] [Abstract][Full Text] [Related]  

  • 24. On certain effects of dopaminergic agents in pentylenetetrazol convulsions.
    Lazarova MB; Roussinov KS
    Acta Physiol Pharmacol Bulg; 1978; 4(3):50-5. PubMed ID: 751452
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Participation of serotoninergic, GABA-ergic and opiate mechanisms in the genesis of amphetamine stereotypy.
    Petkov V; Markovska V
    Acta Physiol Pharmacol Bulg; 1984; 10(2):3-12. PubMed ID: 6237549
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Differential effects of gamma-aminobutyric acid (GABA)-elevating agents on the neuroleptic-induced activation of striatal tyrosine-hydroxylase: evidence that di-n-propylacetate augments GABAergic neurotransmission.
    Casu M; Gale K
    J Pharmacol Exp Ther; 1981 Apr; 217(1):177-80. PubMed ID: 6110774
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Dopaminergic stimulants and cyclic nucleotides in mouse brain. Effects of dopaminergic antagonists, cholinolytics, and GABA agonists.
    Gumulka SW; Dinnendahl V; Schönhöfer PS; Stock K
    Naunyn Schmiedebergs Arch Pharmacol; 1976 Oct; 295(1):21-6. PubMed ID: 187962
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The effect of manipulation of cholinergic mechanisms on turning behaviour in mice with unilateral destruction of the nigro-neostriatal dopaminergic system.
    Pycock C; Milson J; Tarsy D; Marsden CD
    Neuropharmacology; 1978 Mar; 17(3):175-83. PubMed ID: 565479
    [No Abstract]   [Full Text] [Related]  

  • 29. Differential effects of striatal injections of dopaminergic, cholinergic and GABAergic drugs upon swimming behavior of rats.
    Vrijmoed-de Vries MC; Cools AR
    Brain Res; 1986 Jan; 364(1):77-90. PubMed ID: 3004649
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Evidence for multiple dopamine receptors involved in the modulation of acetylcholine release in the striatum.
    Hársing LG; Vizi ES
    Pol J Pharmacol Pharm; 1985; 37(3):383-96. PubMed ID: 2866504
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Diazepam attenuates the antagonism of haloperidol against apomorphine-induced stereotypic behavior after subchronic but not acute treatment in rats.
    Fuchs V; Coper H; Strauss S; Rommelspacher H
    Naunyn Schmiedebergs Arch Pharmacol; 1986 Oct; 334(2):133-7. PubMed ID: 3024028
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of manipulation of the GABA system on dopamine-related behaviors.
    Sandoval MR; Palermo-Neto J
    Braz J Med Biol Res; 1995 Jan; 28(1):88-99. PubMed ID: 7581034
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of gamma-hydroxybutyric acid, baclofen, aminooxyacetic acid, and apomorphine on dopamine turnover in corpus striatum and limbic system.
    Andén NE
    Adv Biochem Psychopharmacol; 1977; 16():495-9. PubMed ID: 18898
    [No Abstract]   [Full Text] [Related]  

  • 34. GABA and central monoamine release.
    Yessaian NH
    Vopr Biokhim Mozga; 1978; 13():267-78. PubMed ID: 41366
    [No Abstract]   [Full Text] [Related]  

  • 35. gamma-Aminobutyric acid: the essential mediator of behaviour triggered by neostriatally applied apomorphine and haloperidol.
    Cools AR; Janssen HJ
    J Pharm Pharmacol; 1976 Jan; 28(1):70-4. PubMed ID: 6658
    [No Abstract]   [Full Text] [Related]  

  • 36. Effects of some gamma-aminobutyric acid (GABA)-ergic drugs on the dopaminergic control of human growth hormone secretion.
    Koulu M; Lammintausta R; Dahlström S
    J Clin Endocrinol Metab; 1980 Jul; 51(1):124-9. PubMed ID: 6769935
    [No Abstract]   [Full Text] [Related]  

  • 37. Differential neurohumoral modulation of myoclonic and clonic seizures.
    Greer CA; Alpern HP
    Arch Int Pharmacodyn Ther; 1978 Nov; 236(1):74-85. PubMed ID: 34368
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The effect of drugs altering striatal dopamine levels on apomorphine induced stereotypy.
    Feigenbaum JJ; Yanai J; Blass RB; Moon B; Klawans H
    Pharmacol Biochem Behav; 1982 Feb; 16(2):235-40. PubMed ID: 7200236
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of intrastriatal administration of cholinergic and GABAergic agonists on apomorphine-induced circling.
    Kuruvilla A; Uretsky NJ
    Psychopharmacology (Berl); 1984; 84(1):42-7. PubMed ID: 6436889
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Striato-cerebellar pathway controlling cyclic GMP content in the cerebellum: role of dopamine, GABA and enkephalins.
    Biggio G; Corda MG; Casu M; Gessa GL
    Adv Biochem Psychopharmacol; 1978; 18():227-44. PubMed ID: 206110
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.